Prevention of upper gastrointestinal bleeding in critically ill Chinese patients: a randomized, double-blind study evaluating esomeprazole and cimetidine

References

• Cook DJ, Griffith LE, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001;5:368-75
   PubMed Web of Science ®Google Scholar
• Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care 2005;20:35-45
   PubMed Web of Science ®Google Scholar
• Bardou M, Quenot JP, Barkun A. Stress-related mucosal disease in the critically ill patient. Nat Rev Gastroenterol Hepatol 2015;12:98-107
   PubMed Web of Science ®Google Scholar
• Ali T, Harty RF. Stress-induced ulcer bleeding in critically ill patients. Gastroenterol Clin North Am 2009;38:245-65
   PubMed Web of Science ®Google Scholar
• Spirt MJ. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther 2004;26:197-213
   PubMed Web of Science ®Google Scholar
• Chinese Medical Association Surgery Branch. Stress prevention and treatment of mucosal lesions – Chinese general surgery expert consensus. Chin J Prac Surg 2015;35(7):728-30
   Google Scholar
• ASHP. ASHP therapeutic guidelines on stress ulcer prophylaxis. ASHP commission on therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm 1999;56:347-79
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 2017;45:486-552
   PubMed Web of Science ®Google Scholar
• Martin LF, Booth FV, Karlstadt RG, et al. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med 1993;21:19-30
   PubMed Web of Science ®Google Scholar
• Conrad SA, Gabrielli A, Margolis B, et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005;33:760-5
   PubMed Web of Science ®Google Scholar
• Somberg L, Morris J Jr, Fantus R, et al. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease. J Trauma 2008;64:1202-10
   PubMed Web of Science ®Google Scholar
• Metz DC, Fulda GJ, Olsen KM, et al. Intravenous esomeprazole pharmacodynamics in critically ill patients. Curr Med Res Opin 2010;26:1141-8
   PubMed Web of Science ®Google Scholar
• Lin PC, Chang CH, Hsu PI, et al. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Crit Care Med 2010;38:1197-205
   PubMed Web of Science ®Google Scholar
• Barkun AN, Bardou M, Pham CQ, et al. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis. Am J Gastroenterol 2012;107:507-20
   PubMed Web of Science ®Google Scholar
• Alhazzani W, Alenezi F, Jaeschke RZ, et al. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med 2013;41:693-705
   Google Scholar
• Alshamsi F, Belley-Cote E, Cook D, et al. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care 2016;20:120
   PubMed Web of Science ®Google Scholar
• Miner P Jr, Katz PO, Chen Y, et al. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol 2003;98:2616-20
   PubMed Web of Science ®Google Scholar
• Castell DO, Kahrilas PJ, Richter JE, et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 2002;97:575-83
   PubMed Web of Science ®Google Scholar
• Kahrilas PJ, Falk GW, Johnson DA, et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators. Aliment Pharmacol Ther 2000;14:1249-58
   PubMed Web of Science ®Google Scholar
• Richter JE, Kahrilas PJ, Johanson J, et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol 2001;96:656-65
   PubMed Web of Science ®Google Scholar
• Rohss K, Lind T, Wilder-Smith C. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. Eur J Clin Pharmacol 2004;60:531-9
   PubMed Web of Science ®Google Scholar
• Marik PE, Vasu T, Hirani A, et al. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med 2010;38:2222-8
   PubMed Web of Science ®Google Scholar
• Chai WZ, Wang XT, Chen XK, et al. [Stress gastrointestinal bleeding in critically ill patients and its effect on the prognosis]. Zhonghua Wei Chang Wai Ke Za Zhi 2009;12:449-51
   PubMedGoogle Scholar
• Selvanderan SP, Summers MJ, Finnis ME, et al. Pantoprazole or placebo for stress ulcer prophylaxis (POP-UP): randomized double-blind exploratory study. Crit Care Med 2016;44:1842-50
   PubMed Web of Science ®Google Scholar
• Krag M, Perner A, Wetterslev J, et al. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med 2015;41:833-45
   PubMed Web of Science ®Google Scholar
• MacLaren R, Reynolds PM, Allen RR. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med 2014;174:564-74
   PubMed Web of Science ®Google Scholar
• Brophy GM, Brackbill ML, Bidwell KL, et al. Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients. Neurocrit Care 2010;13:176-81
   PubMed Web of Science ®Google Scholar
• Levy MJ, Seelig CB, Robinson NJ, et al. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 1997;42:1255-9
   PubMed Web of Science ®Google Scholar
• Solouki M, Marashian SM, Kouchak M, et al. Comparison between the preventive effects of ranitidine and omeprazole on upper GI bleeding among ICU patients. Tanaffos 2009;8:37-42
   Google Scholar
• Kantonova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepato-Gastronterology 2004;51:757-61
   PubMedGoogle Scholar
• Barletta JF, Bruno JJ, Buckley MS, et al. Stress ulcer prophylaxis. Crit Care Med 2016;44:1395-405
   PubMed Web of Science ®Google Scholar